Position in PRQR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$846,493
+$792,566 QoQ
Shares Held
455,104
+1267.1% QoQ
Ownership
0.322%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 69 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRQR Over Time
Shares Held
Position Value (USD)
Derivatives in PRQR
reported options exposure · as of Mar 31, 2021CallValue
$577,053
CallShares
87,300
PutValue
$186,402
PutShares
28,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names. PRQR ranks #91 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in PRQR
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $846,493 | 455,104 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $53,927 | 33,289 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $323,553 | 160,175 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $22,920 | 10,761 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $30,402 | 14,904 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $121,189 | 91,120 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $30,209 | 11,400 | Shares | Defined | 2025-02-14 | |
| 2023-03-31 | $118,998 | 55,868 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $69,363 | 18,747 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $13,410 | 18,025 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $114,800 | 147,558 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $20,533 | 22,689 | Shares | Defined | 2022-05-17 | |
| 2021-12-31 | $137,563 | 17,174 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $96,103 | 11,482 | Shares | Defined | 2021-11-16 | |
| 2021-03-31 | $219,405 | 33,193 | Shares | Defined | 2021-05-18 | |
| 2021-03-31 | $186,402 | 28,200 | Put | Defined | 2021-05-18 | |
| 2021-03-31 | $577,053 | 87,300 | Call | Defined | 2021-05-18 | |
| 2020-12-31 | $58,090 | 13,831 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $57,537 | 12,012 | Shares | Defined | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||